- Home
- AREC vs SAVA Comparison
AREC vs SAVA Comparison
Compare AREC & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREC
- SAVA
- Stock Information
- Founded
- AREC 2013
- SAVA 1998
- Country
- AREC United States
- SAVA United States
- Employees
- AREC N/A
- SAVA N/A
- Industry
- AREC Coal Mining
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- AREC Energy
- SAVA Health Care
- Exchange
- AREC Nasdaq
- SAVA Nasdaq
- Market Cap
- AREC 78.2M
- SAVA 70.5M
- IPO Year
- AREC 2019
- SAVA N/A
- Fundamental
- Price
- AREC $1.02
- SAVA $2.16
- Analyst Decision
- AREC Strong Buy
- SAVA Buy
- Analyst Count
- AREC 2
- SAVA 2
- Target Price
- AREC $4.00
- SAVA $54.50
- AVG Volume (30 Days)
- AREC 2.0M
- SAVA 842.3K
- Earning Date
- AREC 08-18-2025
- SAVA 08-07-2025
- Dividend Yield
- AREC N/A
- SAVA N/A
- EPS Growth
- AREC N/A
- SAVA N/A
- EPS
- AREC N/A
- SAVA N/A
- Revenue
- AREC $321,142.00
- SAVA N/A
- Revenue This Year
- AREC $25,437.66
- SAVA N/A
- Revenue Next Year
- AREC $156.28
- SAVA N/A
- P/E Ratio
- AREC N/A
- SAVA N/A
- Revenue Growth
- AREC N/A
- SAVA N/A
- 52 Week Low
- AREC $0.38
- SAVA $1.15
- 52 Week High
- AREC $1.68
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- AREC 45.25
- SAVA 48.62
- Support Level
- AREC $1.37
- SAVA $2.33
- Resistance Level
- AREC $1.25
- SAVA $2.72
- Average True Range (ATR)
- AREC 0.17
- SAVA 0.16
- MACD
- AREC -0.04
- SAVA -0.01
- Stochastic Oscillator
- AREC 3.42
- SAVA 17.65
About AREC American Resources Corporation
American Resources Corp constructs and/or purchases and manages a chain of combined gasoline, diesel and natural gas (NG) fueling and service stations; construct conversion factories to convert NG to liquefied natural gas (LNG) and compressed natural gas (CNG); and construct conversion factories to retrofit vehicles currently using gasoline or diesel fuel to also run on NG in the United States and also to build a convenience store to serve its customers in each of its locations. Its segments are AIC focused on the extraction, processing, transportation, and distribution of coal for a variety of industries, with a focus on metallurgical quality coal to the steel industry; RLMT; and EMC.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.